{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:53:00Z","timestamp":1788277980712,"version":"build-2803163510"},"reference-count":46,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Narrowband-ultraviolet B has shown increased efficacy over broadband-ultraviolet B in pruritic skin diseases, such as psoriasis and atopic dermatitis. In patients with chronic pruritus, e.g. in end-stage renal disease, broadband-ultraviolet B is recommended, but narrowband-ultraviolet B has also shown efficacy in reducing pruritus. This randomized, single blinded, non-inferiority study investigated the effects of narrowband-ultraviolet B compared with broadband-ultraviolet B. Patients with chronic pruritus were treated with either broadband- or narrowband-UVB 3 times a week for 6 weeks and clinical response was monitored. Pruritus, sleep disturbance, and the patients\u2019 subjective overall response to treatment were evaluated by the patients on a visual analogue scale (0\u201310). Skin excoriations were evaluated by investigators on a 4-point scale (0\u20133). Both phototherapeutic modalities showed significant antipruritic activity (itch reduction 48% and 66.4%, respectively) by broadband-ultraviolet B and narrowband-ultraviolet B. Narrowband-ultraviolet B proved to be not inferior to broadband-ultraviolet B in treating pruritus in patients with chronic pruritus, assuming a 20% non-inferiority margin.\u00a0<\/jats:p>","DOI":"10.2340\/actadv.v103.9403","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:25:19Z","timestamp":1687785919000},"page":"adv9403","source":"Crossref","is-referenced-by-count":7,"title":["Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study"],"prefix":"10.2340","volume":"103","author":[{"given":"Romana","family":"Kupsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gruber-Wackernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz J.","family":"Legat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"33817","doi-asserted-by":"crossref","unstructured":"Metz M. Treatments for chronic pruritus outside of the box. Exp Dermatol 2019; 28: 1476-1481.","DOI":"10.1111\/exd.14007"},{"key":"33818","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.14007","DOI":"10.1111\/exd.14007"},{"key":"33819","doi-asserted-by":"crossref","unstructured":"Matterne U, Apfelbacher CJ, Loerbroks A, Schwarzer T, B\u00fcttner M, Ofenloch R, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011; 91: 674-679.","DOI":"10.2340\/00015555-1159"},{"key":"33820","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/00015555-1159","DOI":"10.2340\/00015555-1159"},{"key":"33821","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol 2007; 87: 291-294.","DOI":"10.2340\/00015555-0305"},{"key":"33822","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/00015555-0305","DOI":"10.2340\/00015555-0305"},{"key":"33823","doi-asserted-by":"crossref","unstructured":"Pereira MP, Zeidler C, Nau T, Bobko S, Evers AWM, Garcovich S, et al. Position statement: linear prurigo is a subtype of chronic prurigo. J Eur Acad Dermatol Venereol 2019; 33: 263-266.","DOI":"10.1111\/jdv.15275"},{"key":"33824","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.15275","DOI":"10.1111\/jdv.15275"},{"key":"33825","doi-asserted-by":"crossref","unstructured":"Andrade A, Kuah CY, Martin-Lopez JE, Chua S, Shpadaruk V, Sanclemente G, et al. Interventions for chronic pruritus of unknown origin. Cochrane Database Syst Rev 2020; 2020 (1) CD013128.","DOI":"10.1002\/14651858.CD013128.pub2"},{"key":"33826","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/14651858.CD013128.pub2","DOI":"10.1002\/14651858.CD013128.pub2"},{"key":"33827","doi-asserted-by":"crossref","unstructured":"Grundmann S, St\u00e4nder S. Chronic pruritus: clinics and treatment. Ann Dermatol 2011; 23: 1-11.","DOI":"10.5021\/ad.2011.23.1.1"},{"key":"33828","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5021\/ad.2011.23.1.1","DOI":"10.5021\/ad.2011.23.1.1"},{"key":"33829","doi-asserted-by":"crossref","unstructured":"Ishiuji Y. Addiction and the itch-scratch cycle. What do they have in common? Exp Dermatol 2019; 28: 1448-1454.","DOI":"10.1111\/exd.14029"},{"key":"33830","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.14029","DOI":"10.1111\/exd.14029"},{"key":"33831","doi-asserted-by":"crossref","unstructured":"Mack MR, Kim BS. The itch-scratch cycle: a neuroimmune perspective. Trends Immunol 2018; 39: 980-991.","DOI":"10.1016\/j.it.2018.10.001"},{"key":"33832","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.it.2018.10.001","DOI":"10.1016\/j.it.2018.10.001"},{"key":"33833","doi-asserted-by":"crossref","unstructured":"Park J Bin, Jang JY, Kwon DI, Seong SH, Suh KS, Jang MS. The effectiveness of high-dose ultraviolet A-1 phototherapy for acute exacerbation of atopic dermatitis in Asians. Photodermatol Photoimmunol Photomed 2020; 36: 263-270.","DOI":"10.1111\/phpp.12546"},{"key":"33834","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/phpp.12546","DOI":"10.1111\/phpp.12546"},{"key":"33835","doi-asserted-by":"crossref","unstructured":"Yanovsky RL, Huang KP, Buzney EA. Optimizing narrowband UVB phototherapy regimens for psoriasis. Dermatol Clin 2010; 38: 1-10.","DOI":"10.1016\/j.det.2019.08.001"},{"key":"33836","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.det.2019.08.001","DOI":"10.1016\/j.det.2019.08.001"},{"key":"33837","doi-asserted-by":"crossref","unstructured":"Atci T, Baykal C. Efficacy of narrow-band ultraviolet-B therapy in patch-stage mycosis fungoides: a clinical study and review of the literature. Photodermatol Photoimmunol Photomed 2020; 36: 271-277.","DOI":"10.1111\/phpp.12547"},{"key":"33838","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/phpp.12547","DOI":"10.1111\/phpp.12547"},{"key":"33839","doi-asserted-by":"crossref","unstructured":"Pereira MP, Steinke S, Zeidler C, Forner C, Riepe C, Augustin M, et al. European Academy of Dermatology and Venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol 2018; 32: 1059-1065.","DOI":"10.1111\/jdv.14570"},{"key":"33840","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14570","DOI":"10.1111\/jdv.14570"},{"key":"33841","doi-asserted-by":"crossref","unstructured":"Weisshaar E, Kucenic MJ, Fleischer AB. Pruritus: a review. Acta Derm Venereol 2003; 213: 5-32.","DOI":"10.1080\/00015555-0369"},{"key":"33842","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/00015555-0369","DOI":"10.1080\/00015555-0369"},{"key":"33843","doi-asserted-by":"crossref","unstructured":"Ibbotson SH. A perspective on the use of NB-UVB phototherapy vs. PUVA photochemotherapy. Front Med (Lausanne) 2018; 5: 184.","DOI":"10.3389\/fmed.2018.00184"},{"key":"33844","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fmed.2018.00184","DOI":"10.3389\/fmed.2018.00184"},{"key":"33845","doi-asserted-by":"crossref","unstructured":"Singer S, Berneburg M. Phototherapy. J Dtsch Dermatol Ges 2018; 16: 1120.","DOI":"10.1111\/ddg.13646"},{"key":"33846","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ddg.13646","DOI":"10.1111\/ddg.13646"},{"key":"33847","doi-asserted-by":"crossref","unstructured":"Legat FJ. Is there still a role for UV therapy in itch treatment? Exp Dermatol 2019; 28: 1432-1438.","DOI":"10.1111\/exd.14011"},{"key":"33848","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.14011","DOI":"10.1111\/exd.14011"},{"key":"33849","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Kwon P, Hirman J, Perlman AJ, Weisshaar E, Metz M, et al. Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial. J Am Acad Dermatol 2019; 80: 1395.","DOI":"10.1016\/j.jaad.2019.01.052"},{"key":"33850","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.052","DOI":"10.1016\/j.jaad.2019.01.052"},{"key":"33851","doi-asserted-by":"crossref","unstructured":"Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med 2020; 382: 222-232.","DOI":"10.1056\/NEJMoa1912770"},{"key":"33852","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1912770","DOI":"10.1056\/NEJMoa1912770"},{"key":"33853","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med 2020; 382: 706-716.","DOI":"10.1056\/NEJMoa1908316"},{"key":"33854","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1908316","DOI":"10.1056\/NEJMoa1908316"},{"key":"33855","doi-asserted-by":"crossref","unstructured":"Qureshi AA, Abate LE, Yosipovitch G, Friedman AJ. A systematic review of evidence-based treatments for prurigo nodularis. J Am Acad Dermatol 2019; 80: 756-764.","DOI":"10.1016\/j.jaad.2018.09.020"},{"key":"33856","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.020","DOI":"10.1016\/j.jaad.2018.09.020"},{"key":"33857","doi-asserted-by":"crossref","unstructured":"Nakamura M, Koo JYM. Phototherapy for the treatment of prurigo nodularis: a review. Dermatol Online J 2016; 22: 13030.","DOI":"10.5070\/D3224030653"},{"key":"33858","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5070\/D3224030653","DOI":"10.5070\/D3224030653"},{"key":"33859","doi-asserted-by":"crossref","unstructured":"Maul JT, Kretschmer L, Anzengruber F, Pink A, Murer C, French LE, et al. Impact of UVA on pruritus during UVA\/B phototherapy of inflammatory skin diseases: a randomized double-blind study. J Eur Acad Dermatol Venereol 2017; 31: 1208-1213.","DOI":"10.1111\/jdv.13994"},{"key":"33860","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.13994","DOI":"10.1111\/jdv.13994"},{"key":"33861","doi-asserted-by":"crossref","unstructured":"Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003; 139: 223-224.","DOI":"10.1001\/archderm.139.2.223"},{"key":"33862","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/archderm.139.2.223","DOI":"10.1001\/archderm.139.2.223"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/9403\/19094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/9403\/19094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:25:34Z","timestamp":1687785934000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/9403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2340\/actadv.v103.9403","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,26]]}}}